Literature DB >> 29217977

Combined Treatment of 'Vigabatrin and Corticoids' for Infantile Spasms: A Superiority Complex or Truly Superior to Corticoids Monotherapy?

Ajay Gupta.   

Abstract

Entities:  

Year:  2017        PMID： 29217977      PMCID： PMC5706355          DOI： 10.5698/1535-7597.17.6.355

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  8 in total

1.  Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: a multi-centre randomised trial.

Authors:  Katrina Darke; Stuart W Edwards; Eleanor Hancock; Anthony L Johnson; Colin R Kennedy; Andrew L Lux; Richard W Newton; Finbar J K O'Callaghan; Christopher M Verity; John P Osborne
Journal:  Arch Dis Child       Date:  2010-05       Impact factor: 3.791

2.  The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14 days: a multicentre, randomised controlled trial.

Authors:  Andrew L Lux; Stuart W Edwards; Eleanor Hancock; Anthony L Johnson; Colin R Kennedy; Richard W Newton; Finbar J K O'Callaghan; Christopher M Verity; John P Osborne
Journal:  Lancet       Date:  2004 Nov 13-19       Impact factor: 79.321

3.  Evidence-based guideline update: medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society.

Authors:  C Y Go; M T Mackay; S K Weiss; D Stephens; T Adams-Webber; S Ashwal; O C Snead
Journal:  Neurology       Date:  2012-06-12       Impact factor: 9.910

4.  Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): a randomised, multicentre, open-label trial.

Authors:  Finbar J K O'Callaghan; Stuart W Edwards; Fabienne Dietrich Alber; Eleanor Hancock; Anthony L Johnson; Colin R Kennedy; Marcus Likeman; Andrew L Lux; Mark Mackay; Andrew A Mallick; Richard W Newton; Melinda Nolan; Ronit Pressler; Dietz Rating; Bernhard Schmitt; Christopher M Verity; John P Osborne
Journal:  Lancet Neurol       Date:  2016-11-10       Impact factor: 44.182

Review 5.  A proposal for case definitions and outcome measures in studies of infantile spasms and West syndrome: consensus statement of the West Delphi group.

Authors:  Andrew L Lux; John P Osborne
Journal:  Epilepsia       Date:  2004-11       Impact factor: 5.864

Review 6.  Infantile spasms: a U.S. consensus report.

Authors:  John M Pellock; Richard Hrachovy; Shlomo Shinnar; Tallie Z Baram; David Bettis; Dennis J Dlugos; William D Gaillard; Patricia A Gibson; Gregory L Holmes; Douglas R Nordl; Christine O'Dell; W Donald Shields; Edwin Trevathan; James W Wheless
Journal:  Epilepsia       Date:  2010-10       Impact factor: 5.864

7.  The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14 months: a multicentre randomised trial.

Authors:  Andrew L Lux; Stuart W Edwards; Eleanor Hancock; Anthony L Johnson; Colin R Kennedy; Richard W Newton; Finbar J K O'Callaghan; Christopher M Verity; John P Osborne
Journal:  Lancet Neurol       Date:  2005-11       Impact factor: 44.182

Review 8.  Infantile epileptic encephalopathy with hypsarrhythmia (infantile spasms/West syndrome).

Authors:  Richard A Hrachovy; James D Frost
Journal:  J Clin Neurophysiol       Date:  2003 Nov-Dec       Impact factor: 2.177
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.